KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cognex (CGNX) Cash & Equivalents (2016 - 2025)

Historic Cash & Equivalents for Cognex (CGNX) over the last 17 years, with Q4 2025 value amounting to $262.9 million.

  • Cognex's Cash & Equivalents rose 4128.61% to $262.9 million in Q4 2025 from the same period last year, while for Dec 2025 it was $262.9 million, marking a year-over-year increase of 4128.61%. This contributed to the annual value of $262.9 million for FY2025, which is 4128.61% up from last year.
  • Cognex's Cash & Equivalents amounted to $262.9 million in Q4 2025, which was up 4128.61% from $245.9 million recorded in Q3 2025.
  • Over the past 5 years, Cognex's Cash & Equivalents peaked at $395.5 million during Q4 2023, and registered a low of $138.9 million during Q1 2024.
  • Its 5-year average for Cash & Equivalents is $205.5 million, with a median of $186.1 million in 2021.
  • As far as peak fluctuations go, Cognex's Cash & Equivalents soared by 4868.24% in 2023, and later crashed by 5017.08% in 2024.
  • Over the past 5 years, Cognex's Cash & Equivalents (Quarter) stood at $186.2 million in 2021, then fell by 2.57% to $181.4 million in 2022, then grew by 11.73% to $202.7 million in 2023, then dropped by 8.17% to $186.1 million in 2024, then surged by 41.29% to $262.9 million in 2025.
  • Its Cash & Equivalents stands at $262.9 million for Q4 2025, versus $245.9 million for Q3 2025 and $179.3 million for Q2 2025.